Trials / Recruiting
RecruitingNCT07130981
Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
Evaluation of Body Composition, Psychosocial Factors, and Drug-Related Problems in Relation to Clinical Progression in Cancer Patients Receiving Immune Checkpoint Inhibitors
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Hacettepe University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Conditions
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2025-09-01
- Completion
- 2026-01-01
- First posted
- 2025-08-19
- Last updated
- 2025-08-24
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07130981. Inclusion in this directory is not an endorsement.